Bender Analytical Holding led a $25m Series B investment in AMT Medical.

Bender Analytical Holding, a Dutch venture capital firm focused on high-impact medtech innovation, leda $25m Series B investment in AMT Medical, a Netherlands-based developer of sutureless coronary artery bypass technology, with the participation of Invest-NL a private equity firm, the European Innovation Council a venture capital firm, and Oost NL, a private equity firm. “We are proud to support AMT as they work toward FDA clearance to bring their technology to the market in the U.S. This marks a key milestone in improving patient outcomes," Johan Bender, Bender Analytical Holding CEO.